Skip to content
Hair Pipeline
← Remedies and supplements

Does vitamin D help hair loss?

Three meta-analyses found low vitamin D more often in people with alopecia areata and other non-scarring hair loss than in people without it, but studies of that kind cannot show that the shortage caused the hair loss. We found no placebo-controlled trial of vitamin D tablets for any kind of hair loss. In the only study we found that compared vitamin D alone with other treatments, in women with female pattern hair loss, vitamin D alone produced no significant improvement. Dermatology reviews advise checking for a deficiency in alopecia areata and treating one if found, which is a different thing from taking vitamin D to grow hair.

What the association studies found

A 2018 meta-analysis pooled 14 studies of 1,255 people with alopecia areata, the autoimmune kind, and 784 without. Average vitamin D was lower in the alopecia group and the odds of deficiency were 3.89 times higher, but the authors found no clear link between how low the level was and how much hair had been lost. A 2025 meta-analysis of 23 studies in alopecia areata pointed the same way; its authors wrote that the high heterogeneity among the studies "significantly weakens the credibility of the aggregated evidence". A 2024 meta-analysis of all non-scarring hair loss, 3,374 patients and 7,296 controls in 23 studies, found odds of deficiency 3.11 times higher. A 2019 review calls the results in female pattern hair loss and telogen effluvium conflicting.

Why that does not prove a cause

Most of the pooled studies compared people who already had hair loss with people who did not, at a single point, so they cannot show which came first; the 2025 authors suggest longitudinal research to investigate whether the link is causal. Low vitamin D is also common without hair loss. In one study cited by the 2019 review, 96.7% of 30 people with alopecia areata were below 20 ng/mL, and so were 73.3% of 30 healthy controls. Another study it cites, which followed 55,929 women in the US Nurses' Health Study, found no significant link between vitamin D intake and later alopecia areata. Cut-offs vary too: the US Food and Nutrition Board, as quoted by the NIH, considers 20 ng/mL or more enough for most people.

Vitamin D tablets: what has been tested

We found no placebo-controlled trial of oral vitamin D for any kind of hair loss. In a 2022 study, 45 women with female pattern hair loss were split into three groups for six months: minoxidil with oral vitamin D, minoxidil alone, or vitamin D alone. Vitamin D alone produced no significant improvement on the Ludwig scale or under the dermatoscope; the authors report that the combination did better than minoxidil alone. Two studies in telogen effluvium gave vitamin D to every patient. In Egypt, 40 women whose vitamin D averaged 13 ng/mL took 5,000 IU a day for three months, and their average score on a 1-to-6 shedding scale fell from 5.5 to 1.75. In Pakistan, 40 women took 200,000 IU every two weeks, six doses, and more than eight in ten were judged improved on a hair-pull test and their own satisfaction; the paper does not report their vitamin D levels. Neither study had an untreated group, and telogen effluvium usually gets better without treatment, according to the British Association of Dermatologists.

Creams and injections are a different treatment

Some alopecia areata studies apply calcipotriol, a vitamin D analogue, to the bald patches, or inject vitamin D3 into them. That is a local treatment, not a supplement, and its results say nothing about tablets. A 2026 meta-analysis of nine such studies, with 621 people, mostly with mild to moderate alopecia areata, reported an overall success rate of about 54% for vitamin D3 and its analogues, alone or added to other treatments. Only one of the nine trials reported blinding both patients and assessors, the review did not assess baseline vitamin D levels, and the pooled estimate for topical treatment against placebo was not statistically significant, although the authors describe it as effective. Injected vitamin D3 did worse than the treatments it was compared with, a steroid injection and bimatoprost. A 2025 review suggests vitamin D may reduce relapses, but its evidence on relapse comes mainly from creams and injections, and it calls that evidence inconclusive. For tablets, it describes a report of three children and one study in which every deficient patient was given vitamin D: about a quarter regrew all their hair, though severity scores showed no significant difference.

Too much vitamin D

EFSA's upper limit for adults is 100 micrograms (4,000 IU) a day, set to avoid persistently high calcium in the urine, and the NIH gives the same figure. Both telogen effluvium studies above went beyond it: 5,000 IU a day in one, and single doses 50 times the daily limit in the other. A 2025 case report from New York describes a 72-year-old woman who took 2,000 IU of vitamin D a day plus Nutrafol, a hair supplement with 2,500 IU per serving that she did not know contained vitamin D. Her level reached 121.8 ng/mL, above the normal range of 30 to 80 given in the report, though she had no symptoms. Cutting her own supplement to 1,000 IU left it at 115.1; it fell to 86.5 only after she stopped Nutrafol.

Testing for a deficiency

Reviews of hair loss advise checking vitamin D in people with alopecia areata and supplementing if it is low, and the 2019 review reports that most authors agree on treating a deficiency in other hair loss too. The French Society of Dermatology's public site says a blood test looking for deficiencies, vitamin D among them, is sometimes needed in hair loss. None of the studies above shows a benefit when levels are normal. Health authorities are more reserved about the test. In France, the health authority HAS concluded in 2013 that in most situations it gives no useful information, and the national health insurer covers it in only six, hair loss not among them, adding that outside those six supplementation can be started and monitored without a test. In the US, the Preventive Services Task Force found too little evidence to judge screening adults without symptoms, according to the NIH.

Related questions

Sources

  1. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis · Journal of the European Academy of Dermatology and Venereology, 2018 · PMID 29633370
  2. Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis · Journal of Cosmetic Dermatology, 2025 · PMID 39739356
  3. Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis · Journal of Cosmetic Dermatology, 2024 · PMID 38010941
  4. The Role of Vitamins and Minerals in Hair Loss: A Review · Dermatology and Therapy, 2019 · PMID 30547302
  5. Vitamin D: Fact Sheet for Health Professionals · NIH Office of Dietary Supplements, 2025
  6. Treatment with oral vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss: A comparative clinical and dermoscopic study · Journal of Cosmetic Dermatology, 2022 · PMID 35001510
  7. Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation · International Journal of Trichology, 2023 · PMID 39170090
  8. Efficacy of Oral Vitamin D3 Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium) · Journal of Nutritional Science and Vitaminology, 2021 · PMID 33642467
  9. Supratherapeutic vitamin D with a hair nutraceutical: A case report · JAAD Case Reports, 2025 · PMID 40791753
  10. Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis · Indian Dermatology Online Journal, 2026 · PMID 40814988
  11. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate · EFSA Journal, 2023 · PMID 37560437
  12. La HAS ne reconnaît pas d'utilité au dosage de vitamine D en routine · Haute Autorité de santé, 2013
  13. Dosage de la vitamine D · Assurance Maladie (ameli.fr), 2024
  14. Tout savoir sur l'alopécie · Dermato-Info (Société Française de Dermatologie), 2026
  15. Telogen effluvium · British Association of Dermatologists, 2025
  16. Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications · Skin Appendage Disorders, 2025 · PMID 40433551

Checked against its sources on 2026-10-29, by us, not by a doctor. A research register, not medical advice: talk to a dermatologist about your own case. See why we're not doctors.